Analysts say the for-profit health care sector should remain financially stable in 2018 so long as companies weather looming threats of disruption, regulatory changes and a shift toward outpaitentsurgeries.
Access to affordable medicine is an unmet public health imperative, according to a new report that recommended government drug price negotiation, competition reform and financial transparency to alleviate the issue.
The Brooklyn medical center will dismiss about 3% of the hospital's 6,500-person staff.
Through the Health Wizz app, patients can aggregate their data and receive cryptocurrency in exchange for handing it over to pharmaceutical companies and others.
Apple and Stanford Medicine are launching a research study that uses the Apple Watch to identify irregular heart rhythms. The tech giant is reportedly working on EHRs and other healthcare technologies as well.
Guest Commentary: Tax reform should mean improving the economy, but not at the expense of our healthcare system
Between the Senate's individual mandate repeal and cuts to Medicare and Medicaid, the tax bill, as it stands today, is set to do more harm than good to America's health.
Uncertainty marks the end-of-year negotiations to authorize CHIP, Medicare extenders; insurers anticipate repeal of certain ACA taxes.
Most doctors surveyed for a joint AAFP and Humana report said they are not actively pursuing value-based purchasing opportunities because they aren't sure they actually improve patient care.
While the acquisition of a hospital increased patient revenue, the additional expenses ultimately helped drive down quarterly operating income 58% from the prior year for Chesterfield, Mo.-based Mercy.
Many organizations are scrambling to figure out how to meet requirements for CMS' new quality payment program under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). But while MACRA may be confusing, the underlying principles are simple: provide good care, do it at as low a cost as...
In his initial confirmation testimony, former pharma executive and HHS secretary nominee Alex Azar said he would stop drug manufacturers from gaming the system and blocking generic competitors from the market.
A new study found physician practices that cared for high-risk patients were more likely to receive financial penalties under the CMS' Value-based Payment Modifier program.